Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Financially Preparing for Severe Weather
Dan Geltrude, managing partner at Geltrude & Co., joined Cheddar News to explain how to get a jump on preparing your finances for extreme weather. "The single most important thing is to make sure you have the proper insurance coverage," he said.
Load More